Antidiabetic agents as potential cytotoxic candidates for cancer therapy Cover

.blurhash-client-img { display: none !important; }

Antidiabetic agents as potential cytotoxic candidates for cancer therapy

Forum of Clinical Oncology

Volume 15 (2024): Issue 1 (December 2024)

By: Raniah I. Alnaser, Fawaz A. Alassaf and Mohammed N. Abed

Open Access

|Jun 2025

Authors

Raniah I. Alnaser

raniahimad@yahoo.com

Nineveh Health Directorate, Mosul, Iraq

University of Mosul, College of Pharmacy, Department of Pharmacology and Toxicology, Mosul, Iraq

Fawaz A. Alassaf

University of Mosul, College of Pharmacy, Department of Pharmacology and Toxicology, Mosul, Iraq

Mohammed N. Abed

University of Mosul, College of Pharmacy, Department of Clinical Laboratory Sciences, Mosul, Iraq

DOI: https://doi.org/10.2478/fco-2023-0041 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 68 - 89

Submitted on: Mar 16, 2024

|

Accepted on: Aug 16, 2024

|

Published on: Jun 10, 2025

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Diabetes Mellitus,

Glucose Deprivation,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2025 Raniah I. Alnaser, Fawaz A. Alassaf, Mohammed N. Abed, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 15 (2024): Issue 1 (December 2024)Next article